Qaseem, Amir;
Hicks, Lauri;
Etxeandia-Ikobaltzeta, Itziar;
Shamliyan, Tatyana;
Cooney, Thomas G;
Cross, J. Thomas;
Fitterman, Nick;
Lin, Jennifer S;
Maroto, Miguel;
Obley, Adam J;
Tice, Jeffrey A;
Tufte, Janice.
Osteoporosis is a disease, common in older age, that makes your bones weaker and can lead to a fracture. People with previous fractures and those who have other risk factors for fractures, including family history of fractures, vitamin D deficiency or low calcium intake, smoking, excessive alcohol intake...
Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.
Commercial arrangement
There is a simple discount patient access scheme for maribavir. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisat...
NICE is unable to make a recommendation on angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock. This is because Paion AG did not provide an evidence submission. We will review this decision if the company decides to make a submission....
Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.
Commercial arrangements
There is a simple discount patient access scheme for lenvatinib and a commercial access agreement for pembrolizumab. NHS organisations can g...
Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults.
Commercial arrangement
There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...
Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderately to severely active ulcerative colitis in adults.
Commercial arrangement
There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. ...
The American Society of Addiction Medicine (ASAM) and the American Academy of
Addiction Psychiatry (AAAP) developed this Clinical Practice Guideline on the Management
of Stimulant Use Disorder (hereafter referred to as the Guideline) to provide evidence-based
strategies and standards of care for the trea...
Baraliakos, Xenofon;
Boteva, Boryana;
Bremander, Ann;
Carron, Philippe;
Ciurea, Adrian;
Hooge, Manouk de;
van der Heijde, Désirée;
Gensler, Lianne;
van Gaalen, Floris A;
Géher, Pál;
Hermann, Josef;
Husakova, Marketa;
Kiltz, Uta;
Landewé, Robert B M;
López-Medina, Clementina;
Machado, Pedro M;
Marzo-Ortega, Helena;
Molto, Anna;
Navarro-Compán, Victoria;
Nikiphorou, Elena;
Nissen, Michael J;
Ortolan, Augusta;
Pimentel-Santos, Fernando M;
Poddubnyy, Denis;
Proft, Fabian;
Ramiro, Sofia;
Rudwaleit, Martin;
Sepriano, Alexandre;
Telkman, Mark;
Van den Bosch, Filip E;
Webers, Casper;
Zhao, Sizheng Steven;
Ziade, Nelly.
To update the Assessment of
SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial
spondyloarthritis (axSpA).
Following the EULAR Standardised Operating
Procedures, two systematic literature reviews were
conducted on non-pharmacological and pharmacological
treatm...
La fibrosis quística (FQ) es una enfermedad crónica y progresiva, de origen genético, de herencia autosómica recesiva, causada por mutaciones en el gen que codifica para la proteína reguladora de la conductancia
transmembrana de la fibrosis quística (CFTR su sigla del inglés Cystic Fibrosis Transm...
El Instituto de Evaluación Tecnológica en Salud (IETS) bajo el liderazgo del Ministerio de
Salud y Protección Social (MSPS) inició el proceso de actualización de la “Guía de Práctica
Clínica para el diagnóstico y tratamiento de Linfoma de Hodgkin (LH) y Linfoma no Hodgkin
(LNH) en niños, niñ...
